No, this instrument does not give the minister that ability.
In fact, there was an interim marketing authorization set of provisions that was introduced earlier into the Food and Drugs Act with the same aim, to make it more efficient, but those sunsetted after two years. Looking back, they did not get us to the efficiency we were looking for. So there is no fast-tracking in this process in terms of the scientific assessment. What we're carving back on is the amount of time it takes to express, after the scientific assessment, in the rule.